Autopsy report · NCT00861887

Extended Treatment With Vancomycin for Clostridium Difficile Colitis

“Difficult enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Corewell Health East

Sponsor type

University, hospital or other

Conditions

Clostridium Difficile Colitis

Interventions

Standard Vancomycin; Extended Vancomycin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
  “difficulty in enrollment” (95% match in meaning)
• Maintenance Dosing of Vitamin D in Crohn's Disease
  “Difficulties with enrollment” (94% match in meaning)
• Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
  “Difficulties of enrollment” (93% match in meaning)
• Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
  “Difficulty with enrollment” (93% match in meaning)
• Clinical Trial With Mesalamine 1g Suppositories
  “Enrollment difficulties” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.